Sharda Cropchem Q2 FY27 revenue up 13% to ₹1,051.7 Cr, PAT up 23%; H1 PAT down 17% on prior-year forex gains
Q2 FY27 revenue up 13% to Rs 1,051.7 Cr, EBITDA up 18%, PAT up 23%; H1 PAT down 17% on higher forex gains in H1FY26.
By ScoutQuest · · 1 min read
- Q2 FY27 revenue
- Rs 1,051.7 Cr, up 13% YoY
- Q2 FY27 EBITDA
- Rs 164.5 Cr (+18%)
- Q2 FY27 PAT
- Rs 91.7 Cr (+23%)
- Period
- Quarter and half year ended 30th September, 2026
- Positioning
- Sharda Cropchem describes itself as an asset-light, registration-led crop protection company with operations in 80+ countries, sourcing from partner manufacturers and selling via 525+ distributors.
📉 Q2 FY27 revenue from operations was Rs 1,051.7 Cr, up 13% YoY, with gross margin at 35.9% (+140 bps), EBITDA of Rs 164.5 Cr (+18%) and PAT of Rs 91.7 Cr (+23%). For H1 FY27 revenue rose 11% to Rs 2,125.5 Cr and EBITDA 22% to Rs 342.9 Cr, but PAT fell 17% to Rs 179.7 Cr, which the company attributes to higher forex gains in H1FY26.
💰 FY26 revenue was Rs 5,267.6 Cr with EBITDA of Rs 1,039.5 Cr (19.7% margin) and PAT of Rs 681.0 Cr; RoCE was 30.4% and RoE 24.2%. The balance sheet shows no borrowings at Mar-26, total equity of Rs 3,250.5 Cr at Sep-26, and trade receivables down to Rs 1,460.9 Cr from Rs 2,389.3 Cr while inventories rose to Rs 1,529.0 Cr.
📌 The company says its model rests on owning registrations and dossiers in its own name while partners handle active ingredient manufacturing (primarily from China) and formulation, keeping it capital efficient.
🔬 Management states its next phase priorities are forward integration through a factory-to-farmer sales force, deeper distribution in existing markets with selective new geographies, continued investment in off-patent molecule registrations, and operational efficiency, while maintaining prudent capital allocation and working capital discipline.
Also from Sharda Cropchem
Q2 FY27: Revenue up 13% to Rs. 1,052 crores, EBITDA up 18%; FY27 guidance of 10–15% growth maintained
30 Oct 2026
Board approves Q2/H1 FY27 unaudited results; auditors give unmodified review conclusion
30 Oct 2026
Sharda Cropchem schedules 2QFY27 post-results analyst/investor conference call on 2 Nov 2026, hosted by Antique
27 Oct 2026
More numbers
- Revenue from operations, Q2 FY271,051.7 (₹ Cr.)
- Revenue growth YoY, Q2 FY27+13%
- EBITDA, Q2 FY27164.5 (₹ Cr.)
- PAT, Q2 FY2791.7 (₹ Cr.)
- PAT growth YoY, Q2 FY27+23%
- Revenue from operations, H1 FY272,125.5 (₹ Cr.)
- PAT, H1 FY27179.7 (₹ Cr.)
- PAT change YoY, H1 FY27(17%)
- Total equity, Sep-263,250.5 (₹ Cr.)
- Revenue from operations, FY265,267.6 (₹ Cr.)
- PAT, FY26681.0 (₹ Cr.)
- RoCE, FY2630.4%
- Distributors in network525
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.